Arbogast v. Pfizer

CourtDistrict Court, D. Massachusetts
DecidedFebruary 9, 2023
Docket1:22-cv-10156
StatusUnknown

This text of Arbogast v. Pfizer (Arbogast v. Pfizer) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Arbogast v. Pfizer, (D. Mass. 2023).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS __________________________________________ ) BRENT ANDREW BRACKETT ARBOGAST, ) ) Plaintiff, ) ) v. ) Case No. 22-cv-10156-DJC ) PFIZER; SHEEHAN, PHINNEY, BASS & ) GREEN, P.A.; JOHN BRACK; KERRI ) LEWANDOWSKI; LEIGH COWDRICK; ) MICHAEL J. LAMBERT; THOMAS M. ) CLOSSON, ) ) Defendants. ) __________________________________________)

MEMORANDUM AND ORDER

CASPER, J. February 9, 2023

I. Introduction Plaintiff Brent Arbogast (“Arbogast”) has filed this lawsuit pro se against Defendants Pfizer, John Brack, Kerri Lewandowski and Leigh Cowdrick (collectively, “Wyeth Defendants”), Thomas Closson (“Closson”), Michael Lambert (“Lambert”) and the law firm Sheehan, Phinney, Bass & Green, P.A. (“Sheehan P.A.”) alleging various claims under the Racketeer Influenced and Corrupt Organizations Act (“RICO”) (Counts I–VI), a claim under 42 U.S.C. § 1983 against Closson, Lambert and Sheehan (Count VII), fraudulent inducement against Pfizer, Brack and Cowdrick (Count VIII), fraudulent misrepresentation against Closson, Lambert and Sheehan (Count IX) and against Pfizer and Lewandowski (Count X), a claim under the Massachusetts Civil Rights Act, Mass. Gen. L. c. 12, § 11I, against Pfizer, Closson, Lambert and Sheehan (Count XI) and intentional infliction of emotional distress against all Defendants (Count XII). D. 43. Wyeth Defendants, D. 44, Closson, D. 46, and Lambert and Sheehan P.A., D. 50, have moved to dismiss for failure to state a claim upon which relief can be granted. For the reasons stated below, the Court ALLOWS Wyeth Defendants’ motion to dismiss, D. 44, ALLOWS Closson’s motion to dismiss, D. 46, and ALLOWS Lambert and Sheehan P.A.’s motion to dismiss, D. 50. II. Standard of Review On a motion to dismiss for failure to state a claim upon which relief can be granted pursuant

to Fed. R. Civ. P. 12(b)(6), the Court must determine if the facts alleged “plausibly narrate a claim for relief.” Schatz v. Republican State Leadership Comm., 669 F.3d 50, 55 (1st Cir. 2012) (citation omitted). Reading the complaint “as a whole,” the Court must conduct a two-step, context-specific inquiry. García-Catalán v. United States, 734 F.3d 100, 103 (1st Cir. 2013). First, the Court must perform a close reading of the claim to distinguish the factual allegations from the conclusory legal allegations contained therein. Id. Factual allegations must be accepted as true, while conclusory legal conclusions are not entitled credit. Id. Second, the Court must determine whether the factual allegations present a “reasonable inference that the defendant is liable for the misconduct alleged.” Haley v. City of Boston, 657 F.3d 39, 46 (1st Cir. 2011) (citation omitted). In sum, the complaint

must provide sufficient factual allegations for the Court to find the claim “plausible on its face.” García-Catalán, 734 F.3d at 103 (citation omitted). The Court remains mindful that a pro se plaintiff is entitled to a liberal reading of his allegations, no matter how unartfully pled. See Haines v. Kerner, 404 U.S. 519, 520–21 (1972); Rodi v. New Eng. Sch. of Law, 389 F.3d 5, 13 (1st Cir. 2004). III. Factual Background The Court draws the following factual allegations from Arbogast’s second amended complaint, D. 43, and accepts them as true for purposes of resolving the motions to dismiss. Arbogast began working at Wyeth Pharmaceuticals (“Wyeth”) in Massachusetts in March 2004. See id. ¶¶ 1, 48, 180. Pfizer is the successor company to Wyeth, while John Brack, Kerri Lewandowski and Leigh Cowdrick worked for Wyeth’s human resources department during the relevant period. See id. ¶¶ 5–8. While employed at Wyeth, Arbogast complained that his position was misclassified as being exempt from the overtime compensation requirements of the Fair Labor

Standards Act (“FLSA”), 29 U.S.C. § 213. See id. ¶¶ 12–14, 30–32, 35–38. Wyeth terminated Arbogast from his position on June 30, 2004. Id. ¶¶ 39, 61. Following his termination, in late 2004, Arbogast sought to bring legal claims against Wyeth and asked Closson to represent him. See id. ¶ 100. Closson initially declined because he was not licensed to practice law in Massachusetts but later agreed to represent Arbogast and “stated that a friend was going to sponsor him so he could practice law in Massachusetts.” Id. As alleged, Closson “persuaded [Arbogast] to assign him control of his legal claims against Wyeth” in March 2005 and “directed [Arbogast] not to communicate with anyone except him regarding the Wyeth issue and to forward him all inquiries regarding the matter.” Id. ¶ 120.

In February 2006, Closson drafted a complaint and contacted the law firm Sheehan PA to serve as local counsel in representing Arbogast in his claims against Wyeth. Id. ¶ 90. Attorney Lambert and Sheehan P.A. filed the complaint in this district on Arbogast’s behalf despite Arbogast’s allegation that he had not authorized it. Id. ¶¶ 89, 126. That complaint alleged that Wyeth failed to pay Arbogast overtime compensation and retaliated against him by terminating his employment because he complained “about his misclassification as an exempt employee and the corresponding requirement that he continue to work overtime without receiving the additional compensation required by the Fair Labor Standards Act.” Arbogast v. Wyeth, No. 06-cv-10333- PBS, D. 1 ¶¶ 21, 28 (D. Mass. Feb. 23, 2006). Closson provided Arbogast with a copy of the complaint in Closson’s office on or around March 21, 2006. D. 43 ¶ 129. Closson also presented Arbogast with a contingent fee agreement, which Arbogast signed. See id. ¶¶ 91, 129. On or around June 8, 2006, Closson called Arbogast and told him that the Court required him to present a settlement offer to Wyeth. Id. ¶ 136; see Arbogast v. Wyeth, No. 06-cv-10333- PBS, D. 8 (D. Mass. Apr. 19, 2006) (noticing parties of June 21, 2006 scheduling conference);

D. Mass. L.R. 16.1(c) (stating that “the plaintiff shall present written settlement proposals to all defendants no later than 14 days before the date for the scheduling conference”).1 Lambert filed a statement in that action certifying that he and Arbogast had conferred about establishing a budget for the full course of litigation and “the resolution of the litigation through the use of alternative dispute resolution programs” and, as alleged by Arborgast, such statement “contained a forgery of [Arbogast]’s signature.” D. 43 ¶¶ 103, 139; see Arbogast v. Wyeth, No. 06-cv-10333-PBS, D. 12 (D. Mass. June 16, 2006). After a scheduling conference, Lambert called Arbogast “urging him to settle his claims because both he and the judge believed they lacked merit and the judge wanted the case settled quickly.” D. 43 ¶ 104. Closson participated in negotiations with Wyeth, including

a “court annexed mediation” in Massachusetts that Arbogast also attended. See id. ¶¶ 101, 146; Arbogast v. Wyeth, No. 06-cv-10333-PBS, D. 9/22/06 entry (D. Mass. Sept. 22, 2006) (noting “[m]ediation with principals present set for 10/11/2006”); Arbogast v. Wyeth, No. 06-cv-10333- PBS, D. 15 (D. Mass. Oct. 17, 2006) (reporting results of mediation). On November 2, 2006, Wyeth served Closson an offer of judgment, which Arbogast alleges was improperly not sent to Lambert, and which Closson withheld from Arbogast. D. 43 ¶ 149. Arbogast met with Closson in his office to discuss settlement in December 2006. Id. ¶ 152.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Airframe Systems, Inc. v. Raytheon Co.
601 F.3d 9 (First Circuit, 2010)
United States v. Classic
313 U.S. 299 (Supreme Court, 1941)
Haines v. Kerner
404 U.S. 519 (Supreme Court, 1972)
Polk County v. Dodson
454 U.S. 312 (Supreme Court, 1981)
Lugar v. Edmondson Oil Co.
457 U.S. 922 (Supreme Court, 1982)
West v. Atkins
487 U.S. 42 (Supreme Court, 1988)
Rotella v. Wood
528 U.S. 549 (Supreme Court, 2000)
Boyle v. United States
556 U.S. 938 (Supreme Court, 2009)
Boyle v. Hasbro, Inc.
103 F.3d 186 (First Circuit, 1996)
Salois v. Dime Savings Bank
128 F.3d 20 (First Circuit, 1997)
United States v. Cunan
156 F.3d 110 (First Circuit, 1998)
Efron v. Embassy Suites (Puerto Rico), Inc.
223 F.3d 12 (First Circuit, 2000)
Nieves v. McSweeney
241 F.3d 46 (First Circuit, 2001)
Iannacchino v. Rodolakis
242 F.3d 36 (First Circuit, 2001)
United States v. Gonzalez Gonzalez
257 F.3d 31 (First Circuit, 2001)
Kenda Corp. v. Pot O'Gold Money Leagues, Inc.
329 F.3d 216 (First Circuit, 2003)
Rodi v. Southern New England School of Law
389 F.3d 5 (First Circuit, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
Arbogast v. Pfizer, Counsel Stack Legal Research, https://law.counselstack.com/opinion/arbogast-v-pfizer-mad-2023.